Emergent BioSolutions Spinning Off Biosciences

Emergent BioSolutions (EBS) announced that it will spin off its Biosciences business into a standalone entity. So what do they mean by ‘biosciences’? The new company will ‘focus on providing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. The core technology of the Biosciences company will be its ADAPTIR platform applied to immuno-oncology’. More specifically, the new… Read More »